PillRx only · Injection, Powder, For Solution · Intramuscular
Ceftriaxone Sodium
Ceftriaxone Sodium
9 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US27 NDCs
9 active makers
9 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
ATC—
RxCUI (US)—
US makers9 labelers
Packages43
DEA / ScheduleNone
US acquisition costNADAC · per unit
Average across 22 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.
$1.667
Latest avg · Jun 17, 2026
+33%
Since Feb 19, 2025
9
Active US suppliers
35%
Top-2 supplier share*
Who makes it9 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Hospira, Inc. | unknown | 8 | SUPPLYING |
| Sandoz Inc | unknown | 7 | SUPPLYING |
| Apotex Corp. | unknown | 7 | SUPPLYING |
| Qilu Pharmaceutical Co. Ltd. | unknown | 6 | SUPPLYING |
| Sportpharm LLC | unknown | 4 | SUPPLYING |
| Proficient Rx LP | unknown | 4 | SUPPLYING |
| A-S Medication Solutions | unknown | 4 | SUPPLYING |
| Asclemed USA, Inc. | unknown | 2 | SUPPLYING |
| REMEDYREPACK INC. | repackager | 1 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.